
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma
YiJiang Song, Yanyang Xu, Xiaojun Zhu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 33
YiJiang Song, Yanyang Xu, Xiaojun Zhu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications
Qingshan Huang, Xin Liang, Tingting Ren, et al.
Cellular Oncology (2021) Vol. 44, Iss. 3, pp. 525-539
Closed Access | Times Cited: 76
Qingshan Huang, Xin Liang, Tingting Ren, et al.
Cellular Oncology (2021) Vol. 44, Iss. 3, pp. 525-539
Closed Access | Times Cited: 76
Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy
Xu Cao, Jing Chen, Bolei Li, et al.
Science Advances (2022) Vol. 8, Iss. 11
Open Access | Times Cited: 69
Xu Cao, Jing Chen, Bolei Li, et al.
Science Advances (2022) Vol. 8, Iss. 11
Open Access | Times Cited: 69
Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma
Hu Qian, Ting Lei, Yihe Hu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Hu Qian, Ting Lei, Yihe Hu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Immunometabolism of tumor-associated macrophages: a therapeutic perspective
A. F. Karimova, Adelya R. Khalitova, Роман В. Суезов, et al.
European Journal of Cancer (2025), pp. 115332-115332
Open Access | Times Cited: 1
A. F. Karimova, Adelya R. Khalitova, Роман В. Суезов, et al.
European Journal of Cancer (2025), pp. 115332-115332
Open Access | Times Cited: 1
Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
Lei Yu, Jian Zhang, Yunfeng Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Lei Yu, Jian Zhang, Yunfeng Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Macrophage scavenger receptors: Tumor support and tumor inhibition
Elena Kazakova, Pavel Iamshchikov, Irina Larionova, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 17
Elena Kazakova, Pavel Iamshchikov, Irina Larionova, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 17
The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response
Caterina Cascini, Claudia Chiodoni
Cells (2021) Vol. 10, Iss. 7, pp. 1668-1668
Open Access | Times Cited: 41
Caterina Cascini, Claudia Chiodoni
Cells (2021) Vol. 10, Iss. 7, pp. 1668-1668
Open Access | Times Cited: 41
MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma
Bikesh K. Nirala, Tajhal D. Patel, Lyazat Kurenbekova, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 14
Bikesh K. Nirala, Tajhal D. Patel, Lyazat Kurenbekova, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 14
Tumor-Infiltrating Lymphocytes and Cancer Markers in Osteosarcoma: Influence on Patient Survival
José Casanova, Jani Sofia Almeida, John D. Reith, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6075-6075
Open Access | Times Cited: 28
José Casanova, Jani Sofia Almeida, John D. Reith, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6075-6075
Open Access | Times Cited: 28
Prioritizing Context-Dependent Cancer Gene Signatures in Networks
Enrico Capobianco, Thomas S. Lisse, Sandra Rieger
Cancers (2025) Vol. 17, Iss. 1, pp. 136-136
Open Access
Enrico Capobianco, Thomas S. Lisse, Sandra Rieger
Cancers (2025) Vol. 17, Iss. 1, pp. 136-136
Open Access
Immune classification of osteosarcoma
Trang Le, Sumeyye Su, Leili Shahriyari
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 2, pp. 1879-1897
Open Access | Times Cited: 25
Trang Le, Sumeyye Su, Leili Shahriyari
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 2, pp. 1879-1897
Open Access | Times Cited: 25
Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
Jinpo Yang, Anran Zhang, Huan Luo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Jinpo Yang, Anran Zhang, Huan Luo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Surface Markers and Chemokines/Cytokines of Tumor-Associated Macrophages in Osteosarcoma and Other Carcinoma Microenviornments—Contradictions and Comparisons
Rikito Tatsuno, Yoshihiro Komohara, Cheng Pan, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2801-2801
Open Access | Times Cited: 3
Rikito Tatsuno, Yoshihiro Komohara, Cheng Pan, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2801-2801
Open Access | Times Cited: 3
A detoxified TLR4 agonist inhibits tumour growth and lung metastasis of osteosarcoma by promoting CD8+ cytotoxic lymphocyte infiltration
Ryunosuke Oyama, Akira Nabeshima, Makoto Endo, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Ryunosuke Oyama, Akira Nabeshima, Makoto Endo, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms
Santhasiri Orrapin, Sutpirat Moonmuang, Sasimol Udomruk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Santhasiri Orrapin, Sutpirat Moonmuang, Sasimol Udomruk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes
YiJiang Song, Yanyang Xu, Chuangzhong Deng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
YiJiang Song, Yanyang Xu, Chuangzhong Deng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma
Lei Fan, Jingtao Ru, Tao Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 19
Lei Fan, Jingtao Ru, Tao Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 19
Identification of an early survival prognostic gene signature for localized osteosarcoma patients
Tajhal D. Patel, Sandra L. Grimm, Rupa S. Kanchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Tajhal D. Patel, Sandra L. Grimm, Rupa S. Kanchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model
Trang Le, Sumeyye Su, Leili Shahriyari
Cells (2021) Vol. 10, Iss. 8, pp. 2009-2009
Open Access | Times Cited: 15
Trang Le, Sumeyye Su, Leili Shahriyari
Cells (2021) Vol. 10, Iss. 8, pp. 2009-2009
Open Access | Times Cited: 15
Peripheral Blood Biomarkers CXCL12 and TNFRSF13C Associate with Cerebrospinal Fluid Biomarkers and Infiltrating Immune Cells in Alzheimer Disease
Qianqian Wu, Wei Kong, Shuaiqun Wang
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 7, pp. 1485-1494
Closed Access | Times Cited: 13
Qianqian Wu, Wei Kong, Shuaiqun Wang
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 7, pp. 1485-1494
Closed Access | Times Cited: 13
Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data
Jian Zhang, Chi Huang, Guiqi Zhu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 9
Jian Zhang, Chi Huang, Guiqi Zhu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 9
Identification of two immune subtypes in osteosarcoma based on immune gene sets
Mengkai Yang, Ya Cao, Zhuoying Wang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107799-107799
Closed Access | Times Cited: 11
Mengkai Yang, Ya Cao, Zhuoying Wang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107799-107799
Closed Access | Times Cited: 11
Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity
Ben Wan, Renxian Wang, Jing‐Jun Nie, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 10
Ben Wan, Renxian Wang, Jing‐Jun Nie, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 10
Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
Siddh van Oost, Debora M. Meijer, Marieke L. Kuijjer, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 8
Siddh van Oost, Debora M. Meijer, Marieke L. Kuijjer, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 8